KMC
ABBV icon

Kirr Marbach & Co’s AbbVie ABBV Stock Holding History

Kirr Marbach & Co’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$316K Hold
1,255
– – 0.05% 54
2026
Q1 		$273K Hold
1,255
– – 0.05% 56
2025
Q4 		$287K Hold
1,255
– – 0.05% 55
2025
Q3 		$291K Hold
1,255
– – 0.05% 53
2025
Q2 		$233K Buy
1,255
+40
+3% +$7.43K 0.05% 54
2025
Q1 		$255K Hold
1,215
– – 0.06% 53
2024
Q4 		$216K Hold
1,215
– – 0.05% 57
2024
Q3 		$240K Hold
1,215
– – 0.05% 53
2024
Q2 		$208K Hold
1,215
– – 0.05% 55
2024
Q1 		$221K Buy
+1,215
New +$209K 0.05% 53

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Kirr Marbach & Co's ABBV Position: Q2 2026 in Review

Kirr Marbach & Co held its AbbVie (ABBV) position steady in Q2 2026 at 1,255 shares worth $316K. The position accounts for 0.05% of the portfolio, ranked #54.

Kirr Marbach & Co first reported a position in ABBV in Q1 2024 and has held it in 10 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Kirr Marbach & Co held 1,255 shares of AbbVie worth $316K as of Q2 2026.
  • Kirr Marbach & Co left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.05% of Kirr Marbach & Co's portfolio in Q2 2026, its #54 holding.
  • Kirr Marbach & Co first reported a position in AbbVie in Q1 2024 and has held it in 10 quarters since.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Kirr Marbach & Co's 13F filing for Q2 2026, filed 14 Jul 2026.